Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
about
A Systematic Review of the Immune-Regulating and Anticancer Activities of Pseudolaric Acid B.Inhibiting Interleukin 17 Can Ameliorate the Demyelination Caused by A. cantonensis via iNOS Inhibition.Learning from Job: A Rare Genetic Disease and Lessons of Biblical Proportions.Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.The Balance of Th17 versus Treg Cells in Autoimmunity.Recent advances in ankylosing spondylitis: understanding the disease and management
P2860
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
@en
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
@nl
type
label
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
@en
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
@nl
prefLabel
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
@en
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
@nl
P2093
P2860
P921
P1433
P1476
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
@en
P2093
Johannes Fessler
Martin Stradner
Patrizia Fasching
P2860
P356
10.3390/MOLECULES22010134
P407
P5008
P577
2017-01-14T00:00:00Z